ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract P1-19-40: Apatinib in the treatment of HER-2 negative advanced breast cancer with chest wall metastasis multicenter phase II clinical study
Mapping Intimacies
◽
10.1158/1538-7445.sabcs19-p1-19-40
◽
2020
◽
Author(s):
Huiping Li
◽
Cuizhi Geng
◽
Guohong Song
◽
Hanfang Jiang
◽
Zhongshen Tong
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Study
◽
Advanced Breast Cancer
◽
Chest Wall
◽
Phase Ii
◽
Advanced Breast
◽
Multicenter Phase
◽
Phase Ii Clinical Study
◽
Her 2
Download Full-text
Related Documents
Cited By
References
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct03923179
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Clinical Study
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Advanced Breast
◽
Her2 Positive
◽
Phase Ii Clinical Study
Download Full-text
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)
International Journal of Clinical Oncology
◽
10.1007/s10147-012-0437-1
◽
2012
◽
Vol 18
(4)
◽
pp. 598-606
◽
Cited By ~ 3
Author(s):
Kenjiro Aogi
◽
Toshiaki Saeki
◽
Seigo Nakamura
◽
Masahiro Kashiwaba
◽
Nobuaki Sato
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Systemic Therapy
◽
Phase Ii Study
◽
Advanced Breast
◽
Primary Systemic Therapy
◽
Multicenter Phase
◽
Her 2
Download Full-text
A Multicenter Phase Ii Trial of Nab-Paclitaxel in Combination with Capecitabine in Patients (Pts) with Her-2 Negative and Triple Negative Advanced Breast Cancer (Abc): an Interim Analysis
Annals of Oncology
◽
10.1093/annonc/mdu329.20
◽
2014
◽
Vol 25
◽
pp. iv123
Author(s):
M. Ciccarese
◽
L. Orlando
◽
P. Fedele
◽
P. Schiavone
◽
E. Maiello
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Interim Analysis
◽
Triple Negative
◽
Phase Ii Trial
◽
Advanced Breast
◽
Multicenter Phase
◽
Her 2
Download Full-text
Patients with Locally Advanced Breast Cancer Receiving Intra-arterial Induction Chemotherapy: Report of a Phase II Clinical Study
Induction Chemotherapy
◽
10.1007/978-3-319-28773-7_10
◽
2016
◽
pp. 157-171
Author(s):
Giammaria Fiorentini
◽
Camillo Aliberti
◽
Paolo Coschiera
◽
Virginia Casadei
◽
Luca Mulazzani
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Study
◽
Advanced Breast Cancer
◽
Induction Chemotherapy
◽
Phase Ii
◽
Locally Advanced Breast Cancer
◽
Locally Advanced
◽
Advanced Breast
◽
Phase Ii Clinical Study
Download Full-text
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
The Breast Journal
◽
10.1111/tbj.13856
◽
2020
◽
Vol 26
(9)
◽
pp. 1857-1859
Author(s):
Mariangela Ciccarese
◽
Laura Orlando
◽
Palma Fedele
◽
Paola Schiavone
◽
Evaristo Maiello
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Triple Negative
◽
Phase Ii Trial
◽
Advanced Breast
◽
Multicenter Phase
◽
Her 2
Download Full-text
Phase II clinical study of high-dose toremifene in patients with advanced breast cancer
Journal of Steroid Biochemistry
◽
10.1016/0022-4731(90)90015-k
◽
1990
◽
Vol 36
(3)
◽
pp. 237-238
◽
Cited By ~ 8
Author(s):
H. Modig
◽
S. Borgström
◽
I. Nilsson
◽
G. Westman
Keyword(s):
Breast Cancer
◽
Clinical Study
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Advanced Breast
◽
High Dose
◽
Phase Ii Clinical Study
Download Full-text
Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer
Journal of Clinical Oncology
◽
10.1200/jco.20.4.987
◽
2002
◽
Vol 20
(4)
◽
pp. 987-993
◽
Cited By ~ 7
Author(s):
E. Rivera
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Multicenter Phase
Download Full-text
Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.696
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 696-696
Author(s):
K. Haider
◽
G. Kornek
◽
W. Kwasny
◽
D. Depisch
◽
T. Payrits
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Advanced Breast
◽
Multicenter Phase
◽
Pretreated Patients
Download Full-text
Multicenter Phase II Study of Brequinar Sodium in Patients with Advanced Breast Cancer
American Journal of Clinical Oncology
◽
10.1097/00000421-199312000-00014
◽
1993
◽
Vol 16
(6)
◽
pp. 526-528
◽
Cited By ~ 22
Author(s):
Robert Cody
◽
David Stewart
◽
Marcel DeForni
◽
Malcolm Moore
◽
Brian Dallaire
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Advanced Breast
◽
Multicenter Phase
◽
Brequinar Sodium
Download Full-text
Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast
Annals of Oncology
◽
10.1093/annonc/mdy487.019
◽
2018
◽
Vol 29
◽
pp. x32
Author(s):
V. Quiroga
◽
E. Holgado
◽
J.L. Alonso
◽
R. Andres
◽
F. Moreno Anton
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Advanced Breast
◽
Multicenter Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close